Skip to main navigation Skip to search Skip to main content

Trastuzumab deruxtecan for HER2+ advanced breast cancer

  • Sungkyunkwan University

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Trastuzumab deruxtecan for HER2+ advanced breast cancer'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science